×
验证码:
换一张
忘记密码?
记住我
切换中国科技网通行证登录
×
切换中国科技网通行证登录
登录
中文版
|
English
中国科学院合肥物质科学研究院机构知识库
Knowledge Management System of Hefei Institute of Physical Science,CAS
登录
注册
ALL
ORCID
题名
作者
学科领域
关键词
文献类型
出处
收录类别
出版者
发表日期
存缴日期
资助项目
学科门类
学习讨论厅
图片搜索
粘贴图片网址
首页
研究单元&专题
作者
文献类型
学科分类
知识图谱
新闻&公告
在结果中检索
研究单元&专题
作者
王可 [2]
杨雷 [2]
张晓东 [2]
石磊 [2]
吴军 [2]
陈豫 [1]
更多...
发表日期
2022 [30]
2021 [38]
2020 [5]
语种
英语 [73]
出处
JOURNAL O... [65]
JOURNAL OF... [4]
ASIA-PACIF... [3]
INTERNATIO... [1]
资助项目
Jiangsu He... [4]
AstraZenec... [3]
Akeso Biop... [2]
BeiGene, L... [2]
Jiangsu He... [2]
National N... [2]
更多...
资助机构
National N... [5]
Jiangsu He... [4]
AstraZenec... [3]
Akeso Biop... [2]
BeiGene, L... [2]
Jiangsu He... [2]
更多...
收录类别
SCI [73]
摘要
文献类型
期刊论文 [73]
×
知识图谱
HFCAS OpenIR
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共73条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
期刊影响因子升序
期刊影响因子降序
发表日期升序
发表日期降序
WOS被引频次升序
WOS被引频次降序
提交时间升序
提交时间降序
作者升序
作者降序
Efficacy and safety of niraparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer using an individualized starting dose (PRIME Study): A randomized, double-blind, placebo-controlled, phase 3 trial
期刊论文
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 18
作者:
Li, Ning
;
Zhu, Jianqing
;
Yin, Rutie
;
Wang, Jing
;
Pan, Lingya
;
Kong, Beihua
;
Zheng, Hong
;
Liu, Jihong
;
Wu, Xiaohua
;
Wang, Li
;
Huang, Yi
;
Wang, Ke
;
Zou, Dongling
;
Zhao, Hongqin
;
Wang, Chunyan
;
Lu, Weiguo
;
Lin, An
;
Lou, Ge
;
Li, Guiling
;
Qu, Pengpeng
;
Yang, Hongying
;
Zhen, Xiaoa
;
Hang, Wenzhao
;
Hou, Jianmei
;
Banerjee, Ashish
;
Wu, Lingying
收藏
  |  
浏览/下载:38/0
  |  
提交时间:2022/12/23
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:
Li, Ning
;
Zhang, Youzhong
;
Wang, Jing
;
Zhu, Jianqing
;
Wang, Li
;
Wu, Xiaohua
;
Yao, Desheng
;
Wu, Qiang
;
Liu, Jihong
;
Tang, Junying
;
Yin, Rutie
;
Lou, Ge
;
An, Ruifang
;
Zhang, Guonan
;
Xia, Xiaoping
;
Li, Qingshui
;
Zhu, Yaping
;
Zheng, Hong
;
Yang, Xinfeng
;
Hu, Yuanjing
;
Zhang, Xin
;
Hao, Min
;
Huang, Yi
;
Lin, Zhongqiu
;
Wang, Dong
;
Guo, Xiaoqing
;
Yao, Shuzhong
;
Wan, Xiaoyun
;
Zhou, Huaijun
;
Yao, Liangqing
;
Yang, Xielan
;
Cui, Heng
;
Meng, Yuanguang
;
Zhang, Songling
;
Qu, Jing
;
Zhang, Ben
;
Zou, Jianjun
;
Wu, Lingying
收藏
  |  
浏览/下载:33/0
  |  
提交时间:2022/12/22
Penpulimab plus gemcitabine in combination with cisplatin or anlotinib as first-line treatment for metastatic nasopharyngeal carcinoma (M NPC): A phase II study.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:
Huang, Shuang
;
Chen, Xiaozhong
;
Qu, Song
;
Qu, Shenhong
;
Han, Yaqian
;
Yang, Kunyu
;
Huang, Shiting
;
Li, Min
;
Zhang, Lin
;
Ding, Qian
收藏
  |  
浏览/下载:37/0
  |  
提交时间:2022/12/23
Exploratory hrd and PD-L1 analysis of l-MOCA study: Olaparib maintenance monotherapy in Asian patients with platinum-sensitive relapsed ovarian cancer.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:
Ma, Ding
;
Gao, Qing-Lei
;
Zhu, Jianqing
;
Zhao, Weidong
;
Huang, Yi
;
An, Ruifang
;
Zheng, Hong
;
Qu, Pengpeng
;
Wang, Li
;
Zhou, Qi
;
Wang, Danbo
;
Lou, Ge
;
Wang, Jing
;
Low, John
;
Kong, Beihua
;
Yin, Rutie
;
Xie, Xing
;
Liu, Jihong
;
Sun, Wei
;
Zang, Rongyu
收藏
  |  
浏览/下载:30/0
  |  
提交时间:2022/12/23
A phase Ib study of SHR-1701, a bifunctional fusion protein targeting PD-L1 and TGF-beta, in patients with recurrent or metastatic nasopharyngeal carcinoma (RM-NPC).
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:
Yang, Yunpeng
;
Zhao, Yuangyuan
;
Zhou, Ting
;
Chen, Gang
;
Huang, Yan
;
Liu, Feng
;
Liu, Zhigang
;
Qu, Song
;
Lei, Yu
;
Chen, Xiaozhong
;
Lin, Lizhu
;
Fu, Zhichao
;
Zhang, Xiaojing
;
Yang, Zeyu
;
Huang, Chuanpei
;
Zhang, Li
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2022/12/23
Genomic signatures in young and old Chinese patients with bone and soft tissue tumors.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:
Jin, Gu
;
Yu, Yangyang
;
Zhao, Lele
;
Xiao, Mingzhe
;
Qi, Chuang
收藏
  |  
浏览/下载:41/0
  |  
提交时间:2022/12/23
Apatinib combined with chemotherapy versus single chemotherapy in HER-2 negative advanced breast cancer: A randomized, controlled, open-label phase II study.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:
Chen, Zhanhong
;
Wang, Xiaojia
;
Huang, Jian
;
Zheng, Yabing
;
Shao, Xiying
;
Cao, Wenming
;
Chen, Junqing
;
Ye, Weiwu
;
Ping, Huang
;
Li, Guangliang
;
Lei, Lei
;
Shi, Lei
;
Huang, Yuan
;
Zou, Weibin
;
Wang, Rong
;
Shen, Xia-Bo
;
Lou, Caijin
收藏
  |  
浏览/下载:33/0
  |  
提交时间:2022/12/23
Nimotuzumab plus chemoradiotherapy versus placebo plus chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma (NPC): A prospective, randomized-controlled, double-blinded, multicenter phase III clinical trial.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:
Sun, Yan
;
Hu, Chaosu
;
Lin, Qin
;
Gao, Li
;
Wang, Jianhua
;
Zhu, Xiaodong
;
Hao, Junfang
;
Lang, Jin Yi
;
Wang, Peiguo
;
Ye, Ming
;
Li, Xia
;
Xu, Benhua
;
Wu, Rong
;
Bai, Chunmei
;
You, Qingshan
;
Chen, Xiaozhong
;
Wang, Jun
;
Hu, Desheng
;
Wu, Gang
;
Pan, Jian-Ji
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2022/12/23
A randomized, controlled, multi-center, open-label study of adjuvant nab-paclitaxel plus S-1 (AS) versus capecitabine plus oxaliplatin (CapeOX) for stage III gastric cancer after D2 resection.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:
Yu, Pengfei
;
Du, Yian
;
Xu, Zhiyuan
;
Yang, Litao
;
Ying, Jieer
;
Wang, Yongxiang
;
Chen, Ping
;
Wei, Yunhai
;
Xu, Hongtao
;
Xu, Nong
;
Cheng, Xiangdong
收藏
  |  
浏览/下载:47/0
  |  
提交时间:2022/12/23
A novel patient-derived organoid model for triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy for screening personalized drugs.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:
Liu, Feiyang
;
Ma, Dandan
;
Liu, Qingsong
;
Qi, Xiaowei
收藏
  |  
浏览/下载:37/0
  |  
提交时间:2022/12/23